Holocene Advisors, LP Merck & Co., Inc. Transaction History

Holocene Advisors, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $308 Million - $330 Million	2,484,447 Added 127016.72%	2,486,403 $308 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $53.1 Million - $61.9 Million	-468,909 Reduced 99.58%	1,956 $258,000
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $47.2 Million - $51.3 Million	470,865 New	470,865 $51.3 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $47.5 Million - $53.4 Million	-561,898 Reduced 26.13%	1,588,150 $137 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $25 Million - $28.3 Million	299,087 Added 16.16%	2,150,048 $196 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $136 Million - $153 Million	1,850,961 New	1,850,961 $152 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $25.1 Million - $34.8 Million	-396,687 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $30.8 Million - $34.7 Million	396,687 New	396,687 $36.1 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $235,342 - $276,503	-4,630 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $329,150 - $382,566	-6,459 Reduced 58.25%	4,630 $252,000
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $572,414 - $683,525	11,089	11,089 $624,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.